What are the psychological effects of using synthetic cannabinoids? A systematic review
Hina Akram, Claire Mokrysz, Helen Valerie Curran
Journal of Psychopharmacology February 21, 2019 DOI: 10.1177/0269881119826592 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Cross-sectional Qualitative Peer reviewed |
|---|---|
| Population | Synthetic cannabinoid users, natural cannabis users, and non-users from 17 studies |
| Topics | Anxiety Cannabis |
| Keywords | Synthetic cannabinoids Cognition Cannabinoid receptor agonists Psychological intervention Clinical psychology |
| Citations | 57 |
| Key findings | Acute synthetic cannabinoid use impairs cognitive functioning and alters psychological ratings, and non-intoxicated users show lower cognitive performance and elevated paranoia compared to natural cannabis and non-users. |
Abstract
Background: Synthetic cannabinoids are, typically, full agonists at the cannabinoid CB1 receptor, and therefore considerably more potent than natural cannabis and may have correspondingly more serious psychological effects. Despite government sanctions against their production they continue to be available in ever-increasing varieties over the Internet. The psychological consequences of synthetic cannabinoid use are relatively unknown.
Aim: The purpose of this study was to synthesise the available research on the psychological consequences of synthetic cannabinoid use.
Method: A literature search of three databases was conducted in February 2018, including the following keywords: Spice, synthetic cannabis, cognition, affect, behaviour, psychosis, depression and anxiety.
Results: Seventeen studies involving a variety of participants were eligible for inclusion: one controlled administration study, seven cross-sectional studies, five Internet surveys and four qualitative studies. The controlled administration study showed that, compared to placebo, synthetic cannabinoids acutely affected some aspects of cognitive functioning and subjective psychological ratings. Non-controlled, cross-sectional studies generally showed that synthetic cannabinoid users had lower performance on cognitive tasks and showed elevated symptomatology (e.g. paranoia) compared to both natural cannabis and non-cannabis users. Methodological limitations were noted across different study designs. There is limited research on how doses, frequency or type of synthetic cannabinoid influence outcomes.
Conclusions: Acute synthetic cannabinoid use can result in a range of psychological outcomes and, when non-intoxicated, synthetic cannabinoid users appear to differ from natural cannabis and non-users on various affective and cognitive domains. As synthetic cannabinoid use is increasing in at-risk populations there is an urgent need for more and better research to inform users, professionals and policymakers.
Comparable studies
Other systematic reviews and meta-analyses on cannabis for anxiety, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review | 2020 | Systematic review | |
| Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties | 2020 | Systematic review | |
| “Noids” in a nutshell: everything you (don’t) want to know about synthetic cannabimimetics | 2014 | Systematic review and descriptive analysis | |
| Subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety. Patients with social anxiety disorder or healthy volunteers performing tasks that... | 2024 | Systematic review | |
| Cannabis and Anxiety: A Critical Review | 2024 | Systematic review |
Citations in the library
Cited by 11
- Reviewing the Potential of Psychedelics for the Treatment of PTSD The International Journal of Neuropsychopharmacology March 12, 2020
- Designer drugs: mechanism of action and adverse effects Archives of Toxicology April 1, 2020
- The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective Frontiers in Psychiatry November 20, 2019
- Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis. Psychopharmacology May 1, 2022
- Medical Cannabis sativa (Marijuana or drug type): Psychoactive molecule, Δ9-Tetrahydrocannabinol (Δ9-THC) International Journal of Research and Innovation in Applied Science 2023
and 6 more in the library
Cites 6
- “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report Human Psychopharmacology: Clinical and Experimental July 1, 2013
- A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness. Journal of Psychiatric and Mental Health Nursing June 1, 2016
- Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study British Journal of Pharmacology November 22, 2017
- A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids. Journal for Specialists in Pediatric Nursing April 2014
- A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Annals of emergency medicine October 2012
and 1 more in the library